<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03949777</url>
  </required_header>
  <id_info>
    <org_study_id>1056CLD</org_study_id>
    <nct_id>NCT03949777</nct_id>
  </id_info>
  <brief_title>Validation of Aer-O-Scope Colonoscope System Cecal Intubation</brief_title>
  <official_title>Validation of Aer-O-Scope Colonoscope System Cecal Intubation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>GI View Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>GI View Ltd.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      61 subjects (male or female) between the ages of 45 and 75 will undergo colonoscopy. The&#xD;
      primary outcome is Cecal Intubation&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This will be a prospective single-center non-blinded clinical investigation. Each subject&#xD;
      will undergo a colonoscopy to the cecum with the Aer-O-Scope Colonoscope System. All&#xD;
      pathologies found will be removed. No control group is necessary as the main objective is to&#xD;
      reach the cecum. Either the cecum is intubated or it is not. This is true for all colonoscopy&#xD;
      procedures.&#xD;
&#xD;
      Up to the first ten (10) cases for each physician will be system operation training cases.&#xD;
&#xD;
      The primary endpoint of cecal intubation was chosen as this measure is the first quality&#xD;
      objective when evaluating colonoscopy quality indicators.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 6, 2020</start_date>
  <completion_date type="Actual">November 14, 2021</completion_date>
  <primary_completion_date type="Actual">August 10, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>A single group of subjects will undergo diagnostic, screening or surveillance colonoscopy.</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Aer-O-Scope Validation of Cecal Intubation</measure>
    <time_frame>30 minutes</time_frame>
    <description>The number of subjects for which cecal intubation will be achieved using the Aer-O-Scope Disposable Colonoscope</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">79</enrollment>
  <condition>Colonic Polyp</condition>
  <condition>Colonic Neoplasms</condition>
  <condition>Colonic Diseases</condition>
  <condition>Colon Adenoma</condition>
  <condition>Colon Disease</condition>
  <condition>Colon Adenocarcinoma</condition>
  <condition>Colon Cancer</condition>
  <arm_group>
    <arm_group_label>Study Cohort</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>61 subjects will undergo colonoscopy</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Aer-O-Scope Colonoscopy</intervention_name>
    <description>resection or biopsy of colonic abnormalities for histopathalogical evaluation</description>
    <arm_group_label>Study Cohort</arm_group_label>
    <other_name>therapeutic intervention - polyp resection</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Subject is indicated for screening, diagnostic (minor complaints such as rectal&#xD;
             bleeding or minor abdominal pain) or surveillance colonoscopy&#xD;
&#xD;
          2. Subject willing to undergo colon preparation bowel cleansing&#xD;
&#xD;
          3. Subject between the ages of 45 and 75 (patients between the ages of 45 and 50 must&#xD;
             have a family history of a first degree relative with onset of colon cancer before the&#xD;
             age of 60).&#xD;
&#xD;
          4. Subject is able to understand and willing to sign informed consent form&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Personal history of colorectal neoplasia including familial adenomatous polyposis or&#xD;
             hereditary nonpolyposis, colon cancer (HNPCC).&#xD;
&#xD;
          2. Diagnosis of active (flaring) inflammatory bowel disease (active ulcerative colitis or&#xD;
             Crohn's colitis), bowel obstruction, or acute diverticulitis, or known severe&#xD;
             diverticulosis, fecal incontinence or any known large-bowel disease that would require&#xD;
             a predetermined therapeutic colonoscopy (non-screening, non-diagnostic or&#xD;
             non-surveillance cases)&#xD;
&#xD;
          3. Severe gastrointestinal tract-related symptoms, or complaints, suggesting performance&#xD;
             of a pre-determined therapeutic colonoscopy (non-screening, non-diagnostic or&#xD;
             non-surveillance cases)&#xD;
&#xD;
          4. History of colonic resection&#xD;
&#xD;
          5. Clinically significant cardiovascular or pulmonary disease.&#xD;
&#xD;
          6. Cancer or other life threatening disease or significant chronic condition that puts&#xD;
             the subject at risk.&#xD;
&#xD;
          7. Blood-clotting disorders and/or current anticoagulant therapy (Subjects taking up to&#xD;
             100mg aspirin for prophylactic treatment are acceptable for this study)&#xD;
&#xD;
          8. Pregnancy&#xD;
&#xD;
          9. Previous radiation therapy to the abdomen&#xD;
&#xD;
         10. Morbid Obesity (BMI &gt; 40 kg/m2)&#xD;
&#xD;
         11. Drug abuse or alcoholism&#xD;
&#xD;
         12. Subject is bed-ridden and/or unable to adequately communicate&#xD;
&#xD;
         13. Subject is under custodial care&#xD;
&#xD;
         14. Subject has a history of psychiatric disorders which would prevent compliance with&#xD;
             study instructions&#xD;
&#xD;
         15. Participation in a clinical study within the previous 30 days&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nathan Gluck, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tel Aviv Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sourasky Medical Center</name>
      <address>
        <city>Tel Aviv</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>April 28, 2019</study_first_submitted>
  <study_first_submitted_qc>May 12, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 14, 2019</study_first_posted>
  <last_update_submitted>November 17, 2021</last_update_submitted>
  <last_update_submitted_qc>November 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>screening-colonoscopy</keyword>
  <keyword>diagnostic-colonoscopy</keyword>
  <keyword>surveillance-colonoscopy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colonic Neoplasms</mesh_term>
    <mesh_term>Adenoma</mesh_term>
    <mesh_term>Colonic Diseases</mesh_term>
    <mesh_term>Colonic Polyps</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>No individual patient data will be shared</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

